Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Panbela Therapeutics Inc
(NQ:
PBLA
)
1.110
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.110
Bid (Size)
1.020 (5)
Ask (Size)
1.040 (1)
Prev. Close
1.110
Today's Range
1.110 - 1.110
52wk Range
0.4111 - 23.85
Shares Outstanding
5,127,686
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Panbela Announces Poster Presentation at American Association for Cancer Research:
Today 8:00 EDT
Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Announces Transfer to OTCQB Market
April 16, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
+23.79%
+23.79%
1 Month
N/A
N/A
3 Month
+155.88%
+155.88%
6 Month
+21.01%
+21.01%
1 Year
-94.04%
-94.04%
More News
Read More
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q4 2023
March 26, 2024
Via
InvestorPlace
Recap: Panbela Therapeutics Q4 Earnings
March 26, 2024
Via
Benzinga
Earnings Preview: Panbela Therapeutics
March 25, 2024
Via
Benzinga
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
March 12, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Top 4 Health Care Stocks That Are Preparing To Pump This Month
February 23, 2024
Via
Benzinga
Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements
February 15, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Secures ~$9M in Public Offering
February 01, 2024
Via
Investor Brand Network
Panbela Announces Closing of Approximately $9.0 Million Public Offering
February 01, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
What's Going On With Panbela Therapeutics Stock Today?
January 30, 2024
Via
Benzinga
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
January 30, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher
January 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 29, 2024
Via
Benzinga
Dow Edges Lower; Cardlytics Shares Jump
January 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal
January 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Aclarion (ACON) Stock Down 16% Today?
January 29, 2024
Via
InvestorPlace
Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today?
January 29, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
Via
Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
January 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 29, 2024
Via
InvestorPlace
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
January 29, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
January 26, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.